IDO1 and melanoma: Further, IDO1 activation in melanoma has been demonstrated to recruit myeloid derived suppressor cells (MDSCs) via enhancing Treg numbers, thereby contributing to immune evasion and resistance to immunotherapy (reviewed in [28]).